122 related articles for article (PubMed ID: 37096435)
21. Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study.
Sung KC; Yoo TK; Lee MY; Byrne CD; Zheng MH; Targher G
Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):482-491. PubMed ID: 36727522
[TBL] [Abstract][Full Text] [Related]
22. A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study.
Farrell AM; Magliano DJ; Shaw JE; Thompson AJ; Croagh C; Ryan MC; Howell J
Sci Rep; 2022 Feb; 12(1):1956. PubMed ID: 35121749
[TBL] [Abstract][Full Text] [Related]
23. Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhao Y; Xu H; Li L; Tong N; Liu F
Acta Diabetol; 2023 Feb; 60(2):225-233. PubMed ID: 36319797
[TBL] [Abstract][Full Text] [Related]
24. A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China: a cross-sectional study.
Liu Q; Zhao G; Li Q; Wu W; Zhang Y; Bian H
BMC Gastroenterol; 2022 Nov; 22(1):471. PubMed ID: 36402947
[TBL] [Abstract][Full Text] [Related]
25. A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population.
Zhang YC; Lyu ZY; Ma B; Li LM; Wang W; Sheng C; Dai HJ; Huang YB; Song FF; Song FJ; Chen KX
Hepatol Int; 2022 Aug; 16(4):835-845. PubMed ID: 35701716
[TBL] [Abstract][Full Text] [Related]
26. Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease.
Wong VW; Wong GL; Woo J; Abrigo JM; Chan CK; Shu SS; Leung JK; Chim AM; Kong AP; Lui GC; Chan HL; Chu WC
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2161-2171.e5. PubMed ID: 33137486
[TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
Yang S; Kwak S; Lee JH; Kang S; Lee SP
PLoS One; 2019; 14(11):e0224626. PubMed ID: 31682638
[TBL] [Abstract][Full Text] [Related]
28. NAFLD and MAFLD as emerging causes of HCC: A populational study.
Myers S; Neyroud-Caspar I; Spahr L; Gkouvatsos K; Fournier E; Giostra E; Magini G; Frossard JL; Bascaron ME; Vernaz N; Zampaglione L; Negro F; Goossens N
JHEP Rep; 2021 Apr; 3(2):100231. PubMed ID: 33748726
[TBL] [Abstract][Full Text] [Related]
29. Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.
Gummesson A; Strömberg U; Schmidt C; Kullberg J; Angerås O; Lindgren S; Hjelmgren O; Torén K; Rosengren A; Fagerberg B; Brandberg J; Bergström G
PLoS One; 2018; 13(8):e0202666. PubMed ID: 30133541
[TBL] [Abstract][Full Text] [Related]
30. The relationship between metabolic dysfunction-associated fatty liver disease and low muscle mass in an asymptomatic Korean population.
Seo JY; Cho EJ; Kim MJ; Kwak MS; Yang JI; Chung SJ; Yim JY; Yoon JW; Chung GE
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2953-2960. PubMed ID: 36222309
[TBL] [Abstract][Full Text] [Related]
31. Comparison of MAFLD and NAFLD diagnostic criteria in real world.
Lin S; Huang J; Wang M; Kumar R; Liu Y; Liu S; Wu Y; Wang X; Zhu Y
Liver Int; 2020 Sep; 40(9):2082-2089. PubMed ID: 32478487
[TBL] [Abstract][Full Text] [Related]
32. Nomenclature Dilemma of Metabolic Associated Fatty Liver Disease (MAFLD): Considerable Proportions of MAFLD Are Metabolic Healthy.
Park H; Yoon EL; Kim M; Cho S; Nah EH; Jun DW
Clin Gastroenterol Hepatol; 2023 Apr; 21(4):1041-1049.e3. PubMed ID: 35504562
[TBL] [Abstract][Full Text] [Related]
33. Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes.
Mantovani A; Csermely A; Taverna A; Cappelli D; Benfari G; Bonapace S; Byrne CD; Targher G
Diabetes Metab; 2023 Mar; 49(2):101416. PubMed ID: 36586476
[TBL] [Abstract][Full Text] [Related]
34. Infections at the nexus of metabolic-associated fatty liver disease.
Boeckmans J; Rombaut M; Demuyser T; Declerck B; Piérard D; Rogiers V; De Kock J; Waumans L; Magerman K; Cartuyvels R; Rummens JL; Rodrigues RM; Vanhaecke T
Arch Toxicol; 2021 Jul; 95(7):2235-2253. PubMed ID: 34027561
[TBL] [Abstract][Full Text] [Related]
35. Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ke Y; Liu S; Zhang Z; Hu J
Lipids Health Dis; 2021 May; 20(1):55. PubMed ID: 34034750
[TBL] [Abstract][Full Text] [Related]
36. Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications.
Cheng YM; Wang CC; Kao JH
Hepatol Int; 2023 Apr; 17(2):350-356. PubMed ID: 36471232
[TBL] [Abstract][Full Text] [Related]
37. The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study.
Chen YG; Yang CW; Chung CH; Ho CL; Chen WL; Chien WC
Hepatol Int; 2022 Aug; 16(4):807-816. PubMed ID: 35064545
[TBL] [Abstract][Full Text] [Related]
38. Bariatric Surgery and Metabolic Dysfunction-Associated Fatty Liver Disease: a 2022 Update.
Lazaridis II; Delko T
Praxis (Bern 1994); 2023 Feb; 112(2):97-102. PubMed ID: 36722105
[No Abstract] [Full Text] [Related]
39. Plasma Calprotectin Levels Associate with Suspected Metabolic-Associated Fatty Liver Disease and All-Cause Mortality in the General Population.
Bourgonje AR; van den Berg EH; Kieneker LM; Nilsen T; Hidden C; Bakker SJL; Blokzijl H; Dullaart RPF; van Goor H; Abdulle AE
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555350
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.
Jongraksak T; Sobhonslidsuk A; Jatchavala J; Warodomwichit D; Kaewduang P; Sungkanuparph S
Int J STD AIDS; 2021 Mar; 32(3):266-275. PubMed ID: 33334267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
